GLP-1 Weight Loss: Your Complete Guide for 2026

What Are GLP-1 Medications?

GLP-1 medications are prescription drugs that mimic a natural gut hormone called glucagon-like peptide-1, reducing appetite, slowing stomach emptying, and helping your body regulate blood sugar.

Originally developed for type 2 diabetes, GLP-1 receptor agonists were discovered to cause significant weight loss as a side effect. This led to FDA-approved weight loss formulations like Wegovy (semaglutide) and Zepbound (tirzepatide). The medications work by binding to GLP-1 receptors in the brain's appetite centers, which reduces hunger signals and what researchers call “food noise” — the constant mental preoccupation with eating that many people with obesity experience.

Newer dual-agonist drugs like Mounjaro and Zepbound target both GLP-1 and GIP receptors simultaneously, producing even greater weight loss in clinical trials. In April 2026, the FDA approved Foundayo (orforglipron), the first non-peptide oral GLP-1 that doesn't require injection — a potential game-changer for the estimated 40% of patients who avoid treatment due to needle aversion.

For a deeper dive into the science, read our complete guide to how GLP-1 medications work, including the latest research on food noise reduction and combining GLP-1s with exercise.

How Much Weight Can You Realistically Lose on GLP-1?

Most people lose 15–22% of their body weight on GLP-1 medications, though individual results vary based on genetics, diet, exercise, and the specific drug used.

Clinical trial data paints a clear picture: semaglutide-based drugs (Ozempic, Wegovy) deliver 15–17% average weight loss, while dual-agonist tirzepatide drugs (Mounjaro, Zepbound) push that to 20–22%. For a 250-pound person, that translates to roughly 37–55 pounds over 12–18 months.

However, real-world results often differ from clinical trials. Factors that influence your outcome include:

• Genetics:A landmark 2026 study by 23andMe identified 14 genetic variants that predict GLP-1 response. Some people are “super-responders” while others see minimal effect. Read the genetics study breakdown.
• Exercise: Combining GLP-1s with resistance training can reduce muscle loss by up to 50% and improve body composition significantly. See our exercise guide.
• Muscle preservation: Without exercise, up to 40% of weight lost on GLP-1s may be lean muscle mass rather than fat. Learn about preventing muscle loss.
• Duration:Weight loss typically plateaus at 12–18 months. Most clinical benefits require ongoing treatment.

Perhaps the most important consideration is what happens after stopping: studies show an average regain of about 1.8 pounds per month, with projected full regain in approximately 18 months. Read our weight regain prevention guide.

What Are the Side Effects of GLP-1 Weight Loss Drugs?

The most common GLP-1 side effects are gastrointestinal: nausea (44%), diarrhea (30%), and vomiting (24%). Most are mild, temporary, and improve with gradual dose escalation.

GLP-1 medications slow gastric emptying, which is partly how they reduce appetite — but this same mechanism causes the most common complaints. In clinical trials, roughly 40–70% of participants reported at least one GI side effect, though most resolved within the first 4–8 weeks as the body adjusted to the medication.

Less common but more serious concerns include pancreatitis, gallbladder issues, and a theoretical thyroid cancer risk (observed in rodent studies but not confirmed in humans). The FDA requires a boxed warning about medullary thyroid carcinoma risk on all semaglutide and tirzepatide medications.

Cosmetic side effects have also gained attention, including “Ozempic butt” (sagging skin from rapid fat loss) and facial volume loss sometimes called “Ozempic face.” These are not medically dangerous but reflect the rapid body composition changes these drugs cause.

For a complete breakdown, read our GLP-1 side effects guide and check the latest FDA safety alerts. If you're experiencing side effects, our management strategies guide offers evidence-based tips.